T Omasa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T Omasa

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Cell Transplantation|September 11, 2001

In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failureS Enosawa, T Miyashita, Y Fujita, et al.

Journal of Biochemistry|January 1, 1997

Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78Y Hagihara, K Enjyoji, T Omasa, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 11, 2008

Human CYP3A4-introduced HepG2 cells: in vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activityN Araki, S Tsuruoka, N Wang, et al.

Transplantation Proceedings|December 20, 2000

Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2T Miyashita, S Enosawa, S Suzuki, et al.

Cell Transplantation|January 6, 2001

Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liverS Enosawa, T Miyashita, S Suzuki, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Cell Transplantation|September 11, 2001

In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failureS Enosawa, T Miyashita, Y Fujita, et al.

Journal of Biochemistry|January 1, 1997

Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78Y Hagihara, K Enjyoji, T Omasa, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 11, 2008

Human CYP3A4-introduced HepG2 cells: in vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activityN Araki, S Tsuruoka, N Wang, et al.

Transplantation Proceedings|December 20, 2000

Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2T Miyashita, S Enosawa, S Suzuki, et al.

Cell Transplantation|January 6, 2001

Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liverS Enosawa, T Miyashita, S Suzuki, et al.

Pageof 3